The American College of Medical Genetics has established guidelines for direct-to-consumer genetic testing to ensure informed decision-making. The recommendations include involving a knowledgeable health professional, clear information about test results, and scientific evidence-based testing protocols.
Researchers are exploring non-conventional counseling methods, such as telephone counseling, to broaden accessibility for genetic testing. The study aims to evaluate the effectiveness of telephone genetic counseling versus traditional in-person counseling among women at high risk of carrying a BRCA1/2 mutation.
A study led by scientists at Einstein and Beth Israel found a significant link between the G2019S LRRK2 gene mutation and Parkinson's disease in Ashkenazi Jewish patients. The mutation was detected in 18.3% of patients, highlighting the importance of genetic counseling for early detection and diagnosis.
A new computer program was found to be more effective in increasing knowledge about breast cancer risk and genetic testing among low-risk women, reducing their perceived risk of getting breast cancer. However, one-on-one genetic counseling was superior in helping women better understand their risk and reduce anxiety.
A study found that breast cancer patients with BRCA 1/2 mutations are twice as likely to opt for a double mastectomy after receiving genetic counseling and testing. Genetic counseling and testing have been shown to significantly impact treatment decisions among high-risk patients.
A meta-analysis of genetic counseling for breast, ovarian, and colorectal cancer found improved knowledge of cancer genetics, but no impact on perceived risk. A gene mutation affecting folate metabolism alters the sensitivity of colon and breast cancer cells to chemotherapy drugs.
A landmark study provides accurate lifetime risk estimates for BRCA1 and BRCA2 gene mutations, with women carrying the BRCA1 gene facing a 54% risk of ovarian cancer. The study also highlights the negative impact of obesity and lack of exercise on breast cancer development in women with the mutation.
A study published in the Journal of the National Cancer Institute found that genetic testing using breast cells can accurately predict breast cancer risk. The Gail model, a computer-based predictor, was correlated with DNA deletions and precancerous changes in cells, suggesting an individualized approach to risk assessment.
A recent Yale Cancer Center study reveals that many experienced cancer genetic counselors would pursue genetic testing for BRCA or HNPCC mutations despite concerns about discrimination. However, the majority would not bill insurance companies or use aliases, and would only share test results with physicians.
Researchers confirmed that one type of genetic mutation causes inherited profound deafness, while another does not. Genetic tests found 42% of individuals with moderate to profound congenital deafness had sequence variations in the GJB2 gene.